Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

CardioTech files US for new medical grade antimicrobial polymer

CardioTech International : 20 June, 2007  (New Product)
CardioTech International has filed for a US patent on its proprietary antimicrobial formulation of ChronoFlex medical grade polymer and its fabrication method.
These materials are designed to provide a new method for the medical device industry to better control foreign body-derived infections without the use of antibiotic drugs.

Cardiotech's antimicrobials can be used in devices as a polymer or a coating.

Commenting on the patent filing, Andrew Reed, PhD, CardioTech's vice president of Science and Technology, said, 'With this patent filing, we have introduced a new antimicrobial family of ChronoFlex polymers'.

'Current technology in the marketplace uses antibiotic drugs, which often become depleted in the body and can form antibiotic-resistant bacteria'.

'Moreover, the antimicrobial component of these polymers has been designed to be non-leaching as a result of the polymerisation process'.

'Remaining as a component of the polymer is a vital factor for preventing infection'.

President and CEO Michael Adams noted that, 'Medical device infections cause 70,000 US deaths annually, costing our hospitals an estimated $9 billion'.

'Our antimicrobial polymer technology received a great deal of attention at the Medical Design and Manufacturing - East conference and exposition last week in New York City'.

'The filing for a new patent reflects the increasing value of CardioTech's intellectual property and builds upon our strategy of developing world class advanced materials'.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo